Clinical Trials Directory

Trials / Completed

CompletedNCT04600544

Russian Disc Degeneration Study

Disease-oriented Russian Disc Degeneration Study (RuDDS) Biobank Facilitating Functional Omics Studies of Lumbar Disc Degeneration

Status
Completed
Phase
Study type
Observational
Enrollment
1,070 (actual)
Sponsor
Novosibirsk State University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers

Summary

The main aim of this study is to establish disease-oriented biobank to facilitate research in biology of the lumbar disc degeneration. Diverse biological samples (whole blood, plasma, disc tissue) along with MRI imaging, clinical, socio-demographic and various omics data (e.g. genomic and transcriptomic) will be available for researchers and clinicians for a variety of further multi-omics studies. It will lay the groundwork for the development of early diagnostics of DDD and its personalized treatment. The study is planned to enroll up to 1,100 patients with different grades of lumbar disc degeneration. It is planned to recruit patients within 36 months.

Conditions

Interventions

TypeNameDescription
OTHERNon-interventionalTranslational, observational study

Timeline

Start date
2020-10-16
Primary completion
2022-10-19
Completion
2024-12-10
First posted
2020-10-23
Last updated
2024-12-24

Locations

3 sites across 1 country: Russia

Source: ClinicalTrials.gov record NCT04600544. Inclusion in this directory is not an endorsement.